Entry Details

About the Entry

Category: 
Online > Online Industry News Coverage > Northeast

Title of entry: 
Scrip: Pharma Industry Coverage Beyond the Headlines

Issue or Publication date:
Jan. 1 - Dec. 31, 2024

Publication name: 
Scrip

View Website home page:
https://insights.citeline.com

Links to entry URLs

Please note: These URLs are only required for entries in the Online division categories, or digital entries in appropriate Overall Excellence, Design or All Content division categories.

Entry URL(s), if applicable:
Please enter a URL that will direct judges to the entry: 
https://insights.citeline.com/SC150478/Titans-Of-Pharma-JJ-Back-On-Top-For-CEO-Remuneration/
Additional URLs, if needed:
https://insights.citeline.com/SC150699/Japan-Results-Roundup-Strong-Mainstays-Currency-Windfall-Help-Top-Line/
https://insights.citeline.com/scrip/focus-on-asia/scrip-asia-100/
https://insights.citeline.com/SC150478/Titans-Of-Pharma-JJ-Back-On-Top-For-CEO-Remuneration/
https://insights.citeline.com/SC150017/Proposed-US-BIOSECURE-Act--Do-Lonza-Other-CDMOs-Gain-And-How-Soon/
https://insights.citeline.com/SC150456/Competitive-Dealmaking-Market-Shifts-To-Smaller-MA-Partnering/

Entry Essay: 
Keeping up with the fast-moving biopharmaceutical markets is essential for success. From licensing to clinical trials to competitor activity, from biotech start-ups to multinational giants, Scrip keeps subscribers up to date on developments that matter to them.

Scrip’s articles are researched/written by 40+ global journalists publishing around the clock, covering the spectrum of global commercial pharmaceutical news. They focus on the strategic implications of global commercial pharma news so subscribers can see what developments actually mean for their business.

To provide news to readers in the formats they prefer, Scrip is available from a newly redesigned News & Insights portal. Subscribers can also access Scrip articles on the go via the News & Insights app. Scrip also offers podcasts in four languages.

Supplementing Scrip’s coverage is Citeline’s best-in class, proprietary data, and a global network of key decision makers and industry leaders. Subscribers also have easy access to Ask the Analyst, where they can ask experts questions about our content or market/business issues.

An example of our outstanding reportage includes the Scrip Asia 100 (link below). This comprehensive annual report analyzes the top 100 companies and key trends shaping the APAC pharmaceutical market. The report features:
• Clinical trial and manufacturing trends
• Key challenges and opportunities in China, India, Japan, and South Korea
• Evolving policies and regulations
• Emerging therapies

A reflection of our ongoing commitment to the pharmaceutical industry, for over 20 years we have hosted the Scrip Awards, bringing together over 400 industry leaders to honor and celebrate the finest innovations and accomplishments in global biopharma.

Throughout 2024, Scrip’s content coverage included:

Industry themes
• Artificial intelligence (AI)
• IRA impacts
• Deal making and M&A
• Financing trends
• Biologics patent cliff
• Blockbuster drugs
• Advanced therapies
• China's rapid advance as a source of innovation
• Korean efforts to internationalize
• Japan's ongoing challenges for bioventure funding
• Emerging innovative R&D capabilities of China/India
• US Biosecure Act
• US Election

Annual features
• Scrip Asks…What Does 2024 Hold For Biopharma
• Scrip Perspectives
• Titans of Pharma (link below)
• R&D review and NAS list (with Citeline Pharmaprojects)
• J.P. Morgan (JPM) coverage
• ASCO coverage
• BIO coverage
• ESMO coverage

Quarterly features
• Financing round-up
• Deals round-up
• M&A round-up
• Market snapshot
• Top 10/20 drugs
• APAC quotables

Monthly features
• Deal Watch
• Emerging Company Profiles
• Japanese/Korean/Chinese-language Podcasts

Weekly features
• Stock Watch
• Pipeline Watch
• Finance Watch
• Executives On The Move
• Five Must-Know Things Podcast

Industry events covered in person, including
• American Association for Cancer Research Annual Meeting
• Swiss Biotech Day
• LSX World Congress
• Bio Korea
• ASCO Annual Meeting

Readers regularly acknowledge Scrip’s value: “Scrip is an invaluable source of information and insight about key developments in the biopharmaceutical industry … with crisp perspective on scientific, business and regulatory dynamics.”
- Chris Frates, VP of Corporate Communications and Patient Advocacy, Madrigal Pharmaceuticals.